Skip to content

Effect of oxelidine preanalgesia combined with lumboquadrate block on patients undergoing kidney transplantation

Effect of oxelidine preanalgesia combined with lumboquadrate block on patients undergoing kidney transplantation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500106707
Enrollment
Unknown
Registered
2025-07-29
Start date
2024-11-27
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stage 5 chronic kidney disease

Interventions

Osselidine Group (Group O):Osselidine
Osselidine quadrate block Group (OQL group):Osselidine quadrate block
Quadratus lumbosus block Group (QL group):Quadratus lumbois block
Basic routine anesthesia group (control group):Basic routine anesthesia

Sponsors

The People’s Hospital of Guangxi Zhuang Autonomous Region
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age 18-75 years old; 2. ASA III.-IV. 3.BMI18-29 kg/m^2; 4. Planned to undergo allogeneic kidney transplantation.

Exclusion criteria

Exclusion criteria: 1. History of opioid allergy; 2. History of ropivacaine allergy; 3. Those who refuse to use a self-controlled analgesia (PCA) pump; 4. Opioid dependent and those who take painkillers before surgery; 5. Those with severe mental illness.

Design outcomes

Primary

MeasureTime frame
VAS score;

Secondary

MeasureTime frame
Intraoperative opioid and sedative drug use;Blood creatinine, blood urea nitrogen;Beta-endorphins and cortisol;Inflammatory indicators;Total number of relief analgesia and pump compressions within 48 h after surgery;

Countries

China

Contacts

Public ContactGong Zheng

The People’s Hospital of Guangxi Zhuang Autonomous Region

278387381@qq.com+86 13367617092

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026